Researchers have made significant strides in treating Parkinson’s disease (a neurodegenerative condition that affects more than 10 million people worldwide) using gold nanoparticles. This innovative approach demonstrates the potential to reverse neurological damage in mice by stimulating dopamine-producing neurons and addressing the accumulation of harmful proteins.
The treatment involves nanoparticles approximately 160 nanometers in size, coated with antibodies and peptides designed to restore dopamine levels and dismantle protein aggregates known as alpha-synuclein fibrils.These nanoparticles are activated by near-infrared light, which they convert into heat,
–
.
.
.
